Results 121 to 130 of about 19,011 (195)

Serum Oncostatin M in Ulcerative Colitis Patients and Its Relation to Disease Activity. [PDF]

open access: yesInt J Mol Sci
Jucan AE   +18 more
europepmc   +1 more source

Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma. [PDF]

open access: yesBMC Med
Feinberg D   +15 more
europepmc   +1 more source

Oncostatin M (OSM) [PDF]

open access: yesScience-Business eXchange, 2012
openaire   +1 more source

Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome. [PDF]

open access: yesJ Hum Immun
Andersen S   +8 more
europepmc   +1 more source

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies. [PDF]

open access: yesSignal Transduct Target Ther
Rassner M   +24 more
europepmc   +1 more source

Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis. [PDF]

open access: yesFront Immunol
Giraulo C   +8 more
europepmc   +1 more source

Oncostatin M promotes inflammation in IBD [PDF]

open access: yesNature Reviews Gastroenterology & Hepatology, 2017
openaire   +2 more sources

Home - About - Disclaimer - Privacy